$1.15 0.0% vs prev close
XAIR Stock Price vs. AI Score Data gathered: February 8
3M 33.9%

AI Stock Analysis - Beyond Air (XAIR)

Analysis generated January 13, 2026.

Beyond Air, Inc. is an innovative medical devices company specializing in the delivery of Nitric Oxide (NO) and its applications. The company's portfolio spans the healthcare spectrum, from treating infectious diseases to addressing respiratory ailments. Beyond Air leverages advanced technology to administer NO safely and effectively, positioning itself at the cutting edge of medical innovation.

Read full AI stock Analysis

Stock Alerts - Beyond Air (XAIR)

company logo Beyond Air | February 6
Price is up by 6.2% in the last 24h.
company logo Beyond Air | February 4
Price is down by -7% in the last 24h.
company logo Beyond Air | February 3
Price is up by 6.1% in the last 24h.
company logo Beyond Air | January 28
Price is down by -6.3% in the last 24h.

Download our app to get future alerts delivered in real-time.

About Beyond Air

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system.


Beyond Air
Price $1.15
Target Price Sign up
Volume 333,520
Market Cap $12M
Year Range $0.7 - $5.7
Dividend Yield 0%
Analyst Rating 67% buy
Earnings Date February 13 '26
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '251.8M2.1M-300,000-7.9M-6.8M-1.250
Q2 '251.8M1.6M160,000-7.7M-6.6M-1.530
Q1 '251.2M1.2M-32,000-8M-6.5M-0.090
Q4 '241.1M1.3M-220,000-13M-12M-0.150
Q3 '24800,0001.9M-1.1M-13M-12M-0.280

Insider Transactions View All

Lisi Steven A. filed to buy 3,327,411 shares at $3.2.
July 23 '25
Carey Robert filed to buy 4,076,864 shares at $0.3.
March 17 '25
Carey Robert filed to buy 4,066,864 shares at $0.3.
March 17 '25
Gaul Michael A. filed to buy 94,150 shares at $0.4.
February 21 '25
Carey Robert filed to buy 26,142 shares at $0.
October 1 '24

FAQ - Beyond Air

The Market Cap of Beyond Air is $12M.

Beyond Air will report its next earnings on February 13 '26.

Currently, the price of one share of Beyond Air stock is $1.15.

The XAIR stock price chart above provides a comprehensive visual representation of Beyond Air's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Beyond Air shares. Our platform offers an up-to-date XAIR stock price chart, along with technical data analysis and alternative data insights.

As of our latest update, Beyond Air (XAIR) does not offer dividends to its shareholders. Investors interested in Beyond Air should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

Some of the similar stocks of Beyond Air are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.